Navigation Links
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
Date:11/17/2010

ST. LOUIS, Nov. 17, 2010 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KVa/KVb) announced today that it has entered into an agreement with US Healthcare I, L.L.C. and US Healthcare II, L.L. C. (together, the "Lenders") affiliates of New York-based Centerbridge Partners, L.P ("Centerbridge") for a senior secured debt financing package of up to $120 million consisting of (1) a fully funded $60 million term loan (the "Bridge Loan") that will retire the previously announced $20 million loan provided by the Lenders and provide for general corporate and working capital purposes and (2) a commitment to provide a multi-draw term loan up to an aggregate principal amount of $120 million consisting of three tranches that will be available to the Company for purposes that include the retiring of the Bridge Loan, following its satisfaction of certain conditions, including the pending approval of Gestiva™ which has an U.S. Food and Drug Administration action date of January 13, 2011.

Under the terms of the Bridge Loan agreement, the Company will pay interest at an annual rate of 16.5% (5% of which shall be payable in kind) with a maturity date of March 2013.  The Company has furnished as collateral substantially all assets of the Company to secure the loan.  The Bridge Loan is guaranteed by certain of the Company's domestic subsidiaries and the guarantors furnished as collateral substantially all of their assets to secure the guarantee obligations.

In addition, the Company issued a stock warrant to the Lenders that grants them rights to purchase up to 9,900,000 shares of the Company's Class A Common Stock, par value $.01 per share (the "Initial Warrant").  Upon the completion of a 10-day notice period to stockholders, the Company will issue a second stock warrant that grants the right to purchase up to 2,687,511 shares of the Company's Class A Common Stock, par value $.01 per share (the "Second Warrant," and together with the Initial Warr
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... N.J. , Oct. 22, 2014  Quest Diagnostics ... of diagnostic information services, today announced that its Board ... serve as a director, effective December 1, 2014. Including ... Dr. Leiden is the Chairman, President and CEO of ... years of scientific and commercial experience in the pharmaceutical ...
(Date:10/22/2014)... RIDGE, N.J. , Oct. 22, 2014 /PRNewswire/ ... (RMANJ), a world-renowned leader in the field of ... rapid approach to embryonic screening. The research abstract, ... Society for Reproductive Medicine (ASRM) meeting in ... screening (CCS) and single gene defect (SGD) pre-implantation ...
(Date:10/22/2014)... October 22, 2014 A new ... Market (Product type, Form, End user, Application and Geography) ... Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - ... market. Based on key trends tracked, it is anticipated ... $7.9 billion by 2020, registering a CAGR of 6.2% ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4
... CIVCO Medical Solutions is showcasing its RFSuite RFID ... is also hosting an RFSuite Symposium Monday, August 1st, ... at the Fairmont Waterfront, Vancouver. The event will include ... Click here to view the invitation and register ...
... 20, 2011 CryoLife, Inc. (NYSE: CRY ), ... cardiac and vascular surgery, announced today that 2011 ... 28, 2011.  On that day, the Company will hold a ... to discuss the results, followed by a question and answer ...
Cached Medicine Technology:CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 2CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 3CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results 2
(Date:10/22/2014)... Hay House is pleased to announce the official release ... (Paperback; $10.82) written by the highly esteemed Tommy Rosen, leader ... is meant to help readers of all kinds end their ... Recovery 2.0 is not the average self-help book, or a ... for what comes next. For many, Alcoholics Anonymous ...
(Date:10/22/2014)... October 22, 2014 Best Cheap Hosting ... the world. The site has recently announced that iPower ... supplier for people from around the world. , “iPower ... operation today and is providing various kinds of useful ... company insists on offering excellent customer service and a ...
(Date:10/22/2014)... 22, 2014 Although there are only 24 hours ... many people who have trouble finding time within their busy schedules ... for long periods of time to get in shape. Here are ... on the go. , Change Up Your Commute , Consider ... to add some exercise into your daily routine. If you must ...
(Date:10/22/2014)... 22, 2014 Akeso Biomedical, Inc. ... the treatment of bacterial infections, microbial biofilms, and chronic ... its board of directors. , Dr. Sinskey ... at The Massachusetts Institute of Technology, or MIT. He ... 1968. Dr. Sinskey also holds positions as Co-Director of ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
Breaking Medicine News(10 mins):Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2
... ARLINGTON HEIGHTS, Ill. Using gene therapy, plastic surgeons ... on cancerous tumors on rats with a 79 percent ... the May issue of Plastic and Reconstructive Surgery, the ... Surgeons (ASPS). This new delivery technique, which has ...
... to Cover MLS Events;, Launches User-Generated Video Contest, Winning Entries to ... ... NEW YORK and LOS ANGELES, May 8 Juniper,Content Corporation,s (OTC Bulletin ... their,"Juega Como un MLS Pro" (translated "Play Like an MLS Pro") seven-month,joint ...
... may help to prevent osteoporosis later in life, research ... your teenage daughter to have strong bones? Steer her ... you may help her prevent low bone density later ... the combination of weight-bearing exercise and repetitive, "impact-loading" from ...
... Inc.,("GNC" or the "Company"), the largest global specialty ... for the first,quarter ended March 31, 2008., ... of GNC Parent LLC,which was acquired on March ... and Ontario Teachers, Pension Plan Board ("Teachers"). As ...
... Inc. (Nasdaq:,COWN) today announced its operating results for the quarter ... March 31, 2008 was $55.0 million,representing a decrease of 25% ... ended March 31, 2008, the Company reported net income of,$0.7 ... income of,$2.5 million in the prior year period, or $0.18 ...
... Regular daily activities can,expose us to hundreds of toxins ... the,common body care and household products we use. Toxicologists ... combined in the body and,have named this synergy the ... organ damage, can result., The May issue of ...
Cached Medicine News:Health News:Skin flaps deliver cancer-fighting therapy, ASPS study reveals 2Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 2Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 3Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 4Health News:Soccer's a Winner for Building Bone Health in Girls 2Health News:Soccer's a Winner for Building Bone Health in Girls 3Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 2Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 3Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 4Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 5Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 6Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 7Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 8Health News:General Nutrition Centers, Inc. Reports First Quarter 2008 Financial Results 9Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 2Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 3Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 4Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 5Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 6Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 7Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 8Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 9Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 10Health News:Cowen Group, Inc. Announces 2008 First Quarter Results 11Health News:Natural Solutions May Issue Illustrates 'Cocktail Effect' of Everyday Toxins; Offers Tips to Reduce Toxic Load 2
... The Trans-Blot SD semi-dry transfer ... economical blotting. Using a platinum-coated ... and a stainless steel plate ... SD cell transfers in a ...
... Transfers depurinated DNA and RNA from ... little as 15 minutes ,Increases speed and ... to be applied to gel ,Part of ... transfer and UV crosslinking in 2.5 hours, ...
PosiBlot 30-30 Masks...
... using the Antigen-Antibody Pens-Using a proprietary and ... specialized fountain pens, called Antigen-Antibody pens-TM, that ... the blotting membranes in any form or ... colored dyes helps to see antigen being ...
Medicine Products: